经济困难是患者及其家人在诊断出血液恶性肿瘤后的常见经历，并且与更糟糕的结果相关。医疗费用、生活费用增加、收入贫困和财富不足会导致诊断和治疗血液恶性肿瘤和/或造血细胞移植后出现经济困难。鉴于经济困难的多维性质，需要采取基于多学科团队的方法来解决这一公共卫生危害。血液学家和肿瘤学家可以通过将治疗方案与患者的护理目标相匹配并减少对就业造成干扰的症状负担来减轻经济困难的影响。社会工作者和财务导航员可以协助筛选和资源部署。政策制定者和研究人员可以确定结构和政策变化以防止财务困难。通过减轻患者的这一主要医疗负担，护理团队可以提高血液恶性肿瘤患者的生存率和生活质量。版权所有 © 2024 美国血液学会。

Financial hardship is a common experience for patients and their families after the diagnosis of a hematologic malignancy and is associated with worse outcomes. Healthcare costs, increased costs of living, income poverty, and inadequate wealth contribute to financial hardship following diagnosis and treatment of a hematologic malignancy and/or hematopoietic cell transplant. Given the multidimensional nature of financial hardship, a multidisciplinary team-based approach is needed to address this public health hazard. Hematologists and oncologists may mitigate the impact of financial hardship by matching treatment options with patient goals of care and reducing symptom burden disruptive to employment. Social workers and financial navigators can assist with screening and resource deployment. Policymakers and researchers can identify structural and policy changes to prevent financial hardship. By alleviating this major healthcare burden from patients, care teams may improve survival and quality of life for patients with hematologic malignancies.Copyright © 2024 American Society of Hematology.